These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Overcoming resistance to existing therapies in HIV-infected patients: the role of new antiretroviral drugs. Perno CF; Moyle G; Tsoukas C; Ratanasuwan W; Gatell J; Schechter M J Med Virol; 2008 Apr; 80(4):565-76. PubMed ID: 18297706 [TBL] [Abstract][Full Text] [Related]
10. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience. Joly V; Yeni P Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy. Justesen US Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):20-31. PubMed ID: 16433887 [TBL] [Abstract][Full Text] [Related]
12. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients. Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V; J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728 [TBL] [Abstract][Full Text] [Related]
13. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Neuman MG; Monteiro M; Rehm J Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989 [TBL] [Abstract][Full Text] [Related]
14. Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naive patients. Metzner KJ; Allers K; Rauch P; Harrer T AIDS; 2007 Mar; 21(6):703-11. PubMed ID: 17413691 [TBL] [Abstract][Full Text] [Related]
15. HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors. Jones R; Gazzard B Expert Rev Anti Infect Ther; 2006 Apr; 4(2):303-12. PubMed ID: 16597210 [TBL] [Abstract][Full Text] [Related]
16. [Revised guideline "Antiretroviral Treatment"]. Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2399-405. PubMed ID: 16277129 [TBL] [Abstract][Full Text] [Related]
17. New developments in HIV drug resistance. Cane PA J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i37-40. PubMed ID: 19675018 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity. Di Santo R; Costi R; Artico M; Ragno R; Greco G; Novellino E; Marchand C; Pommier Y Farmaco; 2005 May; 60(5):409-17. PubMed ID: 15910813 [TBL] [Abstract][Full Text] [Related]
19. Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection. Deeks SG; Hoh R; Neilands TB; Liegler T; Aweeka F; Petropoulos CJ; Grant RM; Martin JN J Infect Dis; 2005 Nov; 192(9):1537-44. PubMed ID: 16206068 [TBL] [Abstract][Full Text] [Related]
20. Current developments in HIV chemotherapy. Meadows DC; Gervay-Hague J ChemMedChem; 2006 Jan; 1(1):16-29. PubMed ID: 16892329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]